The upcoming report from CareDx (CDNA) is expected to reveal quarterly loss of $0.19 per share, indicating a decline of 72.7% compared to the year-ago period. Analysts forecast revenues of $63.63 ...
CareDx (CDNA) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- ...
Zacks Investment Research on MSN
CareDx (CDNA) Surges 7.0%: Is This an Indication of Further Gains?
CareDx CDNA shares soared 7% in the last trading session to close at $12.75. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the ...
AZoLifeSciences on MSN
What are Hidden RNAs and How Can You Identify Them in RNA-Seq Data?
Discover the biological significance of hidden RNAs and learn how to detect them in RNA-Seq data using advanced techniques.
Craig-Hallum analyst William Bonello maintained a Buy rating on CareDx (CDNA – Research Report) today. The company’s shares closed last Friday at $22.64. Bonello covers the Healthcare sector, focusing ...
CareDx, Inc. (NASDAQ:CDNA) faces fresh uncertainty as proposed reimbursement changes threaten its core testing business, clouding near-term growth even as the company’s expanding transplant solutions ...
Back in 2020, AMD announced it was splitting its post-GCN architecture into RDNA for gaming, with CDNA for its data center GPUs, with CDNA later being the architecture of its Radeon Instinct AI ...
Crypto.com has secured approval from the Commodity Futures Trading Commission (CFTC) to offer margined derivatives, including ...
Craig-Hallum analyst Alexander Nowak maintained a Hold rating on CareDx (CDNA – Research Report) today. The company’s shares closed yesterday at $9.64. Nowak covers the Healthcare sector, focusing on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback